1. Home
  2. IMRN vs GLBZ Comparison

IMRN vs GLBZ Comparison

Compare IMRN & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • GLBZ
  • Stock Information
  • Founded
  • IMRN 1994
  • GLBZ 1949
  • Country
  • IMRN Australia
  • GLBZ United States
  • Employees
  • IMRN N/A
  • GLBZ 84
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • GLBZ Major Banks
  • Sector
  • IMRN Health Care
  • GLBZ Finance
  • Exchange
  • IMRN Nasdaq
  • GLBZ Nasdaq
  • Market Cap
  • IMRN 15.0M
  • GLBZ 15.6M
  • IPO Year
  • IMRN N/A
  • GLBZ N/A
  • Fundamental
  • Price
  • IMRN $2.20
  • GLBZ $5.36
  • Analyst Decision
  • IMRN Strong Buy
  • GLBZ
  • Analyst Count
  • IMRN 1
  • GLBZ 0
  • Target Price
  • IMRN $5.00
  • GLBZ N/A
  • AVG Volume (30 Days)
  • IMRN 6.6K
  • GLBZ 6.4K
  • Earning Date
  • IMRN 10-22-2024
  • GLBZ 10-29-2024
  • Dividend Yield
  • IMRN N/A
  • GLBZ 7.46%
  • EPS Growth
  • IMRN N/A
  • GLBZ N/A
  • EPS
  • IMRN N/A
  • GLBZ 0.18
  • Revenue
  • IMRN $3,271,194.00
  • GLBZ $11,581,000.00
  • Revenue This Year
  • IMRN N/A
  • GLBZ N/A
  • Revenue Next Year
  • IMRN N/A
  • GLBZ N/A
  • P/E Ratio
  • IMRN N/A
  • GLBZ $28.51
  • Revenue Growth
  • IMRN 171.67
  • GLBZ N/A
  • 52 Week Low
  • IMRN $1.48
  • GLBZ $3.37
  • 52 Week High
  • IMRN $5.96
  • GLBZ $7.16
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 29.63
  • GLBZ 39.75
  • Support Level
  • IMRN $2.66
  • GLBZ $5.12
  • Resistance Level
  • IMRN $2.87
  • GLBZ $5.68
  • Average True Range (ATR)
  • IMRN 0.14
  • GLBZ 0.16
  • MACD
  • IMRN -0.06
  • GLBZ -0.10
  • Stochastic Oscillator
  • IMRN 1.50
  • GLBZ 0.63

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About GLBZ Glen Burnie Bancorp

Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.

Share on Social Networks: